[1] McGuire S. World Cancer Report 2014. Geneva,Switzerland:World Health Organization, international agency for research on cancer, WHO press, 2015[J]. Advances in Nutrition, 2016, 7(2):418-419. [2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians, 2018, 68(6):394-424. [3] Cheng H, Calhoun V. Exploring microstructure with diffusion-weighted imaging:From acquisition to modeling[J]. Journal of Neuroscience Methods, 2021, 363:109335. [4] Partridge S C. Emerging techniques bring diffusion-weighted imaging of the breast into focus[J]. Radiology, 2020, 297(2):313-315. [5] Baltzer P, Mann R M, Iima M, et al. Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group[J]. European Radiology, 2020, 30(3):1436-1450. [6] Deike-Hofmann K, Kuder T, König F, et al. Diffusion-weighted breast imaging[J]. Radiologe, 2018, 58(Suppl 1):14-19. [7] 郭智慧, 胡清林, 杨大学, 等. 乳腺疾病患者血清中肿瘤标志物、细胞因子及唾液酸水平的变化及临床意义[J]. 现代生物医学进展, 2017, 17(33):6549-6552, 6509. [8] Calderón L, Schindler K, Malin S G, et al. Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation[J]. Science Immunology, 2021, 6(61):eabg5003. [9] Lang D, Powell S K, Plummer R S, et al. PAX genes:Roles in development, pathophysiology, and cancer[J]. Biochemical Pharmacology, 2007, 73(1):1-14. [10] Liu W L, Li X X, Chu E S H, et al. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway[J]. Hepatology, 2011, 53(3):843-853. [11] Li X, Huang J B, Luo X R, et al. Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation[J]. International Journal of Biological Sciences, 2018, 14(12):1686-1695. [12] Vidal L J P, Perry J K, Vouyovitch C M, et al. PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells[J]. Molecular Cancer Research:MCR, 2010, 8(3):444-456. [13] Peters N H G M, Borel Rinkes I H M, Zuithoff N P A, et al. Meta-analysis of MR imaging in the diagnosis of breast lesions[J]. Radiology, 2008, 246(1):116-124. [14] Choi S Y, Chang Y W, Park H J, et al. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer[J]. The British Journal of Radiology, 2012, 85(1016):e474-e479. [15] Bansal R, Shah V, Aggarwal B. Qualitative and quantitative diffusion-weighted imaging of the breast at 3T-A useful adjunct to contrast-enhanced MRI in characterization of breast lesions[J]. The Indian Journal of Radiology & Imaging, 2015, 25(4):397-403. [16] 董海波, 王高燕, 李亚迪. 多b值扩散加权成像在乳腺良恶性病变诊断中的应用价值分析[J]. 中华医学杂志, 2017, 97(3):203-207. [17] 李玮, 平学军, 石惠. MR扩散加权成像在乳腺良恶性病变诊断及鉴别诊断中的应用研究[J]. 实用放射学杂志, 2011, 27(3):372-375, 386. [18] Jin Y N, Zhang Y, Cheng J L, et al. Monoexponential, Biexponential, and stretched-exponential models using diffusion-weighted imaging:A quantitative differentiation of breast lesions at 3.0T[J]. Journal of Magnetic Resonance Imaging:JMRI, 2019, 50(5):1461-1467. [19] Iima M, Yano K, Kataoka M, et al. Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging:Differentiation of malignant and benign breast lesions[J]. Investigative Radiology, 2015, 50(4):205-211. [20] Liu C L, Liang C, Liu Z, et al. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions:comparison with conventional DWI[J]. European Journal of Radiology, 2013, 82(12):e782-e789. [21] 刘圆圆, 史大鹏, 窦社伟, 等. MRI平扫结合体素内不相干运动(IVIM)成像在食管胃结合部腺癌术前T分期及病理分化程度的诊断价值[J]. 中国CT和MRI杂志, 2019, 17(4):115-119. [22] 叶鑫, 游宾, 苗劲柏, 等. 磁共振体素内不相干运动成像技术(IVIM)在肺癌术前判断纵隔淋巴结转移的作用初探[J]. 中华胸心血管外科杂志, 2017, 33(4):216-221. [23] 何杰, 张焱, 程敬亮, 等. 双指数模型DWI在乳腺良恶性病变鉴别诊断中的价值[J]. 实用放射学杂志, 2014, 30(7):1137-1140. [24] Bennett K M, Schmainda K M, Bennett (Tong) R, et al. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model[J]. Magnetic Resonance in Medicine, 2003, 50(4):727-734. [25] Mazaheri Y, Afaq A, Rowe D B, et al. Diffusion-weighted magnetic resonance imaging of the prostate:Improved robustness with stretched exponential modeling[J]. Journal of Computer Assisted Tomography, 2012, 36(6):695-703. [26] 李浩杰, 梁丽丽, 李安琴, 等. 拉伸指数模型DWI在鉴别肾乏脂性错构瘤与乳头状肾细胞癌临床价值[J]. 临床放射学杂志, 2017, 36(6):848-851. [27] Sigmund E E, Cho G Y, Kim S, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer[J]. Magnetic Resonance in Medicine, 2011, 65(5):1437-1447. [28] Kwee T C, Galbán C J, Tsien C, et al. Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas[J]. NMR in Biomedicine, 2010, 23(2):179-187. [29] Bai Y, Lin Y S, Tian J, et al. Grading of gliomas by using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging and diffusion kurtosis MR imaging[J]. Radiology, 2016, 278(2):496-504. [30] Bennett K MHyde J S, Schmainda K M. Water diffusion heterogeneity index in the human brain is insensitive to the orientation of applied magnetic field gradients[J]. Magnetic Resonance in Medicine, 2006, 56(2):235-239. [31] Bedair R, Priest A N, Patterson A J, et al. Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models:A feasibility study comparing the baseline and mid-treatment MRI examinations[J]. European Radiology, 2017, 27(7):2726-2736. [32] Steinbach J P, Kozmik Z, Pfeffer P, et al. Overexpression of Pax5 is not sufficient for neoplastic transformation of mouse neuroectoderm[J]. International Journal of Cancer, 2001, 93(4):459-467. |